 |
 |
 |
|
 |
May 8, 2012 |
For Investors/IR Library: Consolidated Financial Report for the 3 Months Ended March 31, 2012
|
|
March 29, 2012 |
Notification of Appointment of A Representative Director
|
|
March 5, 2012 |
Superior Angiogenic Activity of HGF over bFGF or VEGF Published in a Medical Journal
- Better Target for Angiogenic Gene Therapy -
|
|
February 25, 2012: |
For Investors/IR Library: Consolidated Financial Report for the Year Ended December 31, 2011
|
|
January 25, 2012 |
An Academic Research using “Collategene,” a Treatment Agent for Ischemic Disease was Adopted for a Grant in the UK
- A Research on HGF Gene Therapy for Venous Graft Disease by Bristol University -
|
|
December 2, 2011 |
Research Finding Report on and Academic Society Award for Functional Peptide, “COSMEPEPTIN (TM)”
- Findings on COSMEPEPTIN (TM) reported at Anti-Aging Festa 2011; Anti-Aging Medicine Practices -
|
|
November 25, 2011 |
Development of a Novel Molecular Therapy Agent against Joint Contracture was Adopted as A-STEP by JST
- Development of a Novel Molecular Therapy Agent using “Decoy Nucleotides”-
|
|
November 24, 2011 |
Research Findings concerning Anti-Wrinkle, Anti-Sagging and Anti-Microbial Actions by Functional Peptides, “COSMEPEPTIN (TM)”
- Findings on COSMEPEPTIN (TM) Reported at Nikkei BP Health & Beauty Seminar -
|
|
November 10, 2011 |
For Investors/IR Library: Consolidated Financial Report for the 9 Months Ended September 30, 2011
| |
|
|
